Steve is a founder of GSV. He has over 25 years of experience as a finance executive in the life sciences industry and has served as CFO of six companies including AviaraDx, Awarepoint, Sequenom (NASDAQ: SQNM), Sorrento Therapeutics (NASDAQ: SRNE), Cardiff Oncology (NASDAQ: CRDF, formerly Trovagene), and XIFIN. He was responsible for financial planning & strategy, and led funding and exit transactions. In the aggregate, Steve raised over $600 million through venture funding, debt financing, and IPO proceeds and completed four M&A transactions.
Steve was a practicing CPA with Arthur Andersen and holds a BS degree in accounting from Boston University and an MBA from Boston College.